Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,579Revenue $M7,380Net Margin (%)3.9Z-Score1.3
Enterprise Value $M26,585EPS $-0.1Operating Margin %4.3F-Score6
P/E(ttm))80.4Cash Flow Per Share $1.5Pre-tax Margin (%)1.4Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %0Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow3.8y-y EBITDA Growth Rate %51.4ROA % (ttm)1.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)4.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M1,326ROI % (ttm)-9.4Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXVanguard Health Care Fund 2014-12-31 Add0.27%$11.37 - $13.68
($12.78)
$ 16.9733%Add 16.36%59,624,800
BSXRay Dalio 2014-12-31 Add$11.37 - $13.68
($12.78)
$ 16.9733%Add 45.29%89,184
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 16.9733%Reduce -97.34%1,184,730
BSXVanguard Health Care Fund 2014-09-30 Add0.25%$11.92 - $13.29
($12.59)
$ 16.9735%Add 19.88%51,242,050
BSXRay Dalio 2014-09-30 Buy 0.01%$11.92 - $13.29
($12.59)
$ 16.9735%New holding, 61384 sh.61,384
BSXLeon Cooperman 2014-09-30 Sold Out -1.1%$11.92 - $13.29
($12.59)
$ 16.9735%Sold Out0
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 16.9730%Add 16.19%42,743,200
BSXRay Dalio 2014-06-30 Sold Out $12.58 - $13.77
($13.01)
$ 16.9730%Sold Out0
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 16.9730%Reduce -23.25%6,549,479
BSXRay Dalio 2014-03-31 Reduce-0.01%$11.91 - $13.98
($13.08)
$ 16.9730%Reduce -70.15%36,884
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 16.9744%Add 17.65%2,000,000
BSXRay Dalio 2013-12-31 Buy 0.01%$11.18 - $12.38
($11.81)
$ 16.9744%New holding, 123584 sh.123,584
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 16.9744%Reduce -36.64%8,533,099
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 16.9744%Reduce -22.34%45,938,468
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 16.9744%Sold Out0
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 16.9757%Reduce -18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 16.9757%Reduce -27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 16.9757%Reduce -15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 16.9757%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 16.9757%Reduce -69.22%18,744
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BSX Ray Dalio 2014-12-3189,1840.010.01+45.29%
BSX Vanguard Health Care Fund 2014-12-3159,624,8004.491.9+16.36%
BSX PRIMECAP Management 2014-12-3146,957,3493.540.63-0.26%
BSX Michael Price 2014-12-311,980,0000.153.2-1%
BSX Mario Gabelli 2014-12-311,650,4460.120.11-3.14%
BSX Dodge & Cox 2014-12-311,184,7300.090.02-97.34%
Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pierce David ASVP and President, Endoscopy 2015-02-27Sell19,046$16.8-0.24view
Prange KarenSVP&Pres, Uro & Women's Health 2015-02-27Sell1,307$16.8-0.24view
Phalen Michael P.EVP & President, MedSurg 2015-02-27Sell1,819$16.8-0.24view
Pierce David ASVP and President, Endoscopy 2015-02-19Sell11,958$16.461.82view
Phalen Michael P.EVP & President, MedSurg 2015-02-19Sell13,188$16.441.95view
Mirviss Jeffrey B.SVP&Pres, Periph Intervent 2015-02-18Sell19,136$16.352.51view
Fitzgerald Joseph MichaelEVP & President, CRM 2015-02-10Sell61,208$14.6614.32view
Pierce David ASVP and President, Endoscopy 2015-02-09Sell5,000$14.6614.32view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2015-02-06Sell21,408$15.0611.29view
Phalen Michael P.EVP & President, MedSurg 2015-01-20Sell10,000$14.5415.27view

Press Releases about BSX :

    Quarterly/Annual Reports about BSX:

    News about BSX:

    Articles On GuruFocus.com
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
    Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson (JNJ) En Feb 18 2015 
    A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Oct 17 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jul 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jun 26 2014 
    Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jan 15 2014 


    More From Other Websites
    Boston Scientific to Buy Endo International's Urology Business - Analyst Blog Mar 03 2015
    Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors Mar 03 2015
    Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors Mar 03 2015
    Key Analyst Weighs In on Boston Scientific Acquisition Mar 03 2015
    Boston Scientific to Halt Buybacks for Deal Mar 03 2015
    US STOCKS-Wall St. rallies; Nasdaq hits highest level since 2000 Mar 02 2015
    US STOCKS-Wall St. rallies; Nasdaq hits highest level since 2000 Mar 02 2015
    US STOCKS-U.S. stocks rally; Nasdaq hits highest level since 2000 Mar 02 2015
    US STOCKS-U.S. stocks rally; Nasdaq hits highest level since 2000 Mar 02 2015
    US STOCKS-Wall St advances after data and deals; Nasdaq hits 5,000 Mar 02 2015
    US STOCKS-Wall St advances after data and deals; Nasdaq hits 5,000 Mar 02 2015
    'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In... Mar 02 2015
    Boston Scientific to buy Endo division for $1.6 billion Mar 02 2015
    Boston Scientific to buy Endo division for $1.6 billion Mar 02 2015
    Boston Scientific Corporation -- Moody's affirms Boston Scientific's Baa3 rating following news of... Mar 02 2015
    Boston Scientific Buys Endo's Urology Device Business in $1.6 Billion Deal Mar 02 2015
    Endo Beats Q4 Views, Inks Boston Scientific Deal Mar 02 2015
    Boston Scientific buys men's health business of AMS for $1.65B Mar 02 2015
    Endo (ENDP) Beats Q4 Earnings, Announces Divestments - Analyst Blog Mar 02 2015
    Boston Scientific (BSX) Stock Declines Today on $1.65 Billion American Medical Systems Purchase Mar 02 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK